Literature DB >> 6765539

Authenticity and purity of human insulin (recombinant DNA).

I S Johnson.   

Abstract

A summary of the exhaustive analyses of human insulin (recombinant DNA) shows chemical, structural, and biologic equivalence to pancreatic human insulin. The high degree of purity accounts for its lack of pyrogenicity and immunogenic contamination. Human insulin from both the proinsulin and chain combination methods is essentially identical. The role of proinsulin as an alternate route to human insulin, and as a new treatment for diabetes when used alone or in combination with human insulin or connecting peptide, warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765539     DOI: 10.2337/diacare.5.2.s4

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

Review 1.  Human insulin: much ado about one amino acid?

Authors:  G E Sonnenberg; M Berger
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

Review 2.  Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study.

Authors:  A L Puttagunta; E L Toth
Journal:  CMAJ       Date:  1998-02-24       Impact factor: 8.262

Review 3.  Guidelines for using insulin lispro.

Authors:  E L Toth; K C Lee
Journal:  Can Fam Physician       Date:  1998-11       Impact factor: 3.275

4.  Immunogenicity of recombinant DNA human insulin.

Authors:  S E Fineberg; J A Galloway; N S Fineberg; M J Rathbun; S Hufferd
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.